Anti-GPC3 antibody (SALUBRIS)

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameAnti-GPC3 antibody (SALUBRIS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Glypican-3
TargetsGlypican-3
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXinlitai (Chengdu) Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXinlitai (Chengdu) Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A